2m 2m 2m 2m 2m 2m 2m
DYNE THERAPEUTCS (DYN)
NASDAQ
$15.46-$0.36 (-2.25%)
Price as of Oct 02, 2026 6:04 PM EDT- $3.0BMarket Cap
- 26.06%1-Year Change
- BiotechnologyIndustry
DYNE THERAPEUTCS (DYN)
$15.46-$0.36 (-2.25%)
DYN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.82 | ||
Change | -$0.29 (-1.80%) | ||
Open | $16.01 | ||
High | $16.28 | ||
Low | $15.52 | ||
Previous Close | $16.11 | ||
Volume | 3,699,425 | ||
30-Day Average Volume | 3,625,881 | ||
1-Week Change | -4.18% | ||
1-Month Change | -36.97% | ||
1-Year Change | 26.06% | ||
3-Year Change | 76.56% | ||
5-Year Change | -1.56% | ||
Fundamentals | |||
Shares Outstanding | 186.7M | ||
Total Assets | $994.0M | ||
Market Cap | $3.0B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$178.6M | ||
Free Cash Flow | -$131.8M | ||
EBIT | -$174.0M | ||
EBITDA | -$173.4M | ||
Net Working Capital | $859.9M | ||
EPS | -$1.08 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -15 | ||
PEG | 0 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue